Artelo Biosciences (ARTL) Liabilities and Shareholders Equity (2014 - 2025)
Artelo Biosciences (ARTL) posted Liabilities and Shareholders Equity of $2.8 million for Q4 2025, down 40.4% from $4.7 million a year earlier and down 34.4% from the prior quarter.
Powered by 
Analysis
Artelo Biosciences (ARTL) Liabilities and Shareholders Equity (2014 - 2025) Analysis & Trends
Since Q4 2014, Artelo Biosciences has reported Liabilities and Shareholders Equity for 44 quarters.
- Annual Liabilities and Shareholders Equity has declined for four consecutive years, with a five-year compound annual growth rate of -8.5% (FY2020 to FY2025).
- In prior years, Artelo Biosciences' Liabilities and Shareholders Equity was $4.7 million in FY2024 (-64.0%), $13.04 million in FY2023 (-36.1%), $20.42 million in FY2022 (-27.7%) and $28.25 million in FY2021.
- The Q4 2025 figure stands as the lowest quarterly Liabilities and Shareholders Equity since Q3 2019.
- On a year-over-year basis, Liabilities and Shareholders Equity has declined in each of the last 12 quarters, with an average decline of 50.9% over the last eight quarters.
- The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q3 2021, with growth of 253.2%; the weakest was Q1 2025, with a decline of 66.1%.
- According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $4.27 million (Q3 2025), $4.36 million (Q2 2025) and $3.52 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Artelo Biosciences | 80,492.96 | -5.05 Mn | - | 2.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 2.80 Mn |
| Sep 30, 2025 | 4.27 Mn |
| Jun 30, 2025 | 4.36 Mn |
| Mar 31, 2025 | 3.52 Mn |
| Dec 31, 2024 | 4.70 Mn |
| Sep 30, 2024 | 7.14 Mn |
| Jun 30, 2024 | 8.33 Mn |
| Mar 31, 2024 | 10.35 Mn |
| Dec 31, 2023 | 13.04 Mn |
| Sep 30, 2023 | 15.50 Mn |
| Jun 30, 2023 | 16.88 Mn |
| Mar 31, 2023 | 18.48 Mn |
| Dec 31, 2022 | 20.42 Mn |
| Sep 30, 2022 | 22.42 Mn |
| Jun 30, 2022 | 24.41 Mn |
| Mar 31, 2022 | 26.70 Mn |
| Nov 30, 2021 | 29.00 Mn |
| Aug 31, 2021 | 12.64 Mn |
| May 31, 2021 | 12.34 Mn |
| Feb 28, 2021 | 13.44 Mn |
API Access
Artelo Biosciences Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ARTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "ARTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ARTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();